Inicio › Linfoma de Burkitt › Florida

Ensayos clínicos de Linfoma de Burkitt en Florida

15 estudios sobre Linfoma de Burkitt buscan participantes en Florida.

Ciudades en Florida

Texto oficial del estudio (inglés)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Golisano Children's Hospital of Southwest Florida, Fort Myers
UF Health Cancer Institute - Gainesville, Gainesville
Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood
y 9 más

ReclutandoFase 2

366 Days – 46 Years · Todos los sexos · Actualizado el 28 sept 2026 · NCT06124157

Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Moffitt Cancer Center, Tampa

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06144606

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

UF Health Cancer Institute - Gainesville, Gainesville
Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood
Nemours Children's Clinic-Jacksonville, Jacksonville
y 8 más

ReclutandoFase 2

365 Days · Todos los sexos · Actualizado el 25 sept 2026 · NCT06317662

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

Jupiter Medical Center, Jupiter

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 24 sept 2026 · NCT03739814

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

SSAK Partners, Coral Springs
Mayo Clinic - Jacksonville, Jacksonville

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 21 sept 2026 · NCT07648264

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Johns Hopkins All Children's Hospital ( Site 1025), St. Petersburg

ReclutandoFase 1/2

6 Months – 25 Years · Todos los sexos · Actualizado el 17 sept 2026 · NCT06395103

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

H. Lee Moffitt Cancer Center, Tampa

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 8 sept 2026 · NCT03666000

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood
Orlando Health Cancer Institute, Orlando

ReclutandoFase 3

Edades de 18 a 39 · Todos los sexos · Actualizado el 2 sept 2026 · NCT03150693

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Golisano Children's Hospital of Southwest Florida, Fort Myers
UF Health Cancer Institute - Gainesville, Gainesville
Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood
y 9 más

ReclutandoFase 2

Edades de 1 a 30 · Todos los sexos · Actualizado el 1 sept 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Broward Health Medical Center, Fort Lauderdale
Golisano Children's Hospital of Southwest Florida, Fort Myers
UF Health Cancer Institute - Gainesville, Gainesville
y 12 más

ReclutandoFase 3

365 Days – 25 Years · Todos los sexos · Actualizado el 25 ago 2026 · NCT03959085

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

Research Site, Tampa

ReclutandoFase 1/2

Edades de 12 en adelante · Todos los sexos · Actualizado el 19 ago 2026 · NCT06137118

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Mayo Clinic, Clinical Trials Referral Office, Jacksonville

ReclutandoFase 1/2

Edades de 13 a 90 · Todos los sexos · Actualizado el 6 ago 2026 · NCT06533579

Blinatumomab Consolidation in Real World

Mayo Clinic Cancer Center, Jacksonville

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 18 en adelante · Todos los sexos · Actualizado el 31 jul 2026 · NCT07117136

Study of SGR-1505 in Mature B-Cell Neoplasms

Napa Research, Pompano Beach

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 feb 2026 · NCT05544019

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

University of Florida, Gainesville
Nicklaus Children's Hospital, Miami
Johns Hopkins All Children's Hospital, St. Petersburg

ReclutandoFase 2

Edades de 1 a 25 · Todos los sexos · Actualizado el 4 may 2025 · NCT03509961

De ClinicalTrials.gov, datos obtenidos el 29 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.